Screener
Ginkgo Bioworks DNA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Accounts payable | $9,575 | $10,566 |
| Deferred revenue (includes $98 and $98 from related parties) | 13,214 | 18,946 |
| Accrued expenses and other current liabilities (includes $2,513 and zero from related parties) | 49,951 | 66,458 |
| Total current liabilities | 72,740 | 95,970 |
| Non-current liabilities: | ||
| Deferred revenue, net of current portion (includes $64,810 and $64,787 from related parties) | 76,537 | 75,182 |
| Operating lease liabilities, non-current | 404,113 | 417,078 |
| Other non-current liabilities | 16,372 | 22,876 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's total current liabilities?
- Ginkgo Bioworks (DNA) reported total current liabilities of $72.74M in Q2 2026.
- How has Ginkgo Bioworks's total current liabilities changed year-over-year?
- Ginkgo Bioworks's total current liabilities decreased by 24.8% year-over-year, from $96.72M to $72.74M.
- What is the long-term trend for Ginkgo Bioworks's total current liabilities?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's total current liabilities has grown at a 5.6% compound annual growth rate (CAGR), from $73.22M to $95.97M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Ginkgo Bioworks's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude